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Quantification of two isomeric flavones
in rat colon tissue using reverse phase high
performance liquid chromatography
Crystal L. Whitted1, Victoria E. Palau1, Ruben D. Torrenegra2, Oscar E. Rodriguez3 and Sam Harirforoosh1*

Abstract
Background: Antineoplastic activity has been previously shown for two isomeric flavones, 5,7-dihydroxy-3,6,8trimethoxy flavone (flavone A) and 3,5-dihydroxy-6,7,8-trimethoxy flavone (flavone B), against colon cancer cell lines
(Thomas et al. in PLoS ONE 7:e39806, 5). Here, we present modified methods for the extraction and quantification of
flavones A and B in rat colon tissue after intravenous dosing via high performance liquid chromatography, from the
originally described procedure for extraction and quantification in rat plasma (Whitted et al. in J Chromatogr B Analyt
Technol Biomed Life Sci 1001:150–155, 7).
Results: Modifications included tissue homogenization (1 g tissue: 2 mL water), filtration of the supernatant with a
PVDF membrane, and the use of only one calibration curve to determine the concentration of each flavone in colon
tissue. Good separation was achieved and representative equations were linear with r2 ≥ 0.99 for both flavones. Precision and accuracy for flavone A ranged from 0.88–24.03 and 109–116%. Precision and accuracy for flavone B ranged
from 1.62–33.56 and 98–113%. Concentrations of 1639 ± 601 ng/g flavone A and 5975 ± 2480 ng/g of flavone B
were detected in rat colon tissue 6 h post dosing.
Conclusions: Modifications to the extraction methods for flavone A and flavone B from rat colon tissue had good
separation, precision, and accuracy.
Keywords: 5,7-Dihydroxy-3,6,8-trimethoxy flavone, 3,5-Dihydroxy-6,7,8-trimethoxy flavone, HPLC, Colon, Flavonoids,
Cancer
Background
Many flavonoids have been recognized for their antitumor properties [1–4]. It is known that these activities
are greatly determined by their chemical structure which
subsequently dictates their ability to interact with cellular
molecules [1]. This differential effect has been observed
with flavone isomers 5,7-dihydroxy-3,6,8-trimethoxy
flavone (flavone A) and 3,5-dihydroxy-6,7,8-trimethoxy
flavone (flavone B) [5]. Specifically, each isomer has been
shown to target colon cancer cells with distinct phenotypical characteristics via different mechanisms of action
*Correspondence: harirfor@etsu.edu
1
Department of Pharmaceutical Sciences, Gatton College of Pharmacy,
East Tennessee State University, Box 70594, Johnson City,
TN 37614‑1708, USA
Full list of author information is available at the end of the article

[6]. However, it is unknown whether either of these flavones distribute to the colon after intravenous administration of these compounds. Modifications were made
to methods developed for extracting and quantifying
these flavones in rat plasma [7] using reverse phase high
performance liquid chromatography (HPLC). The modifications included preparation of the sample by homogenization in water, filtration using a polyvinylidene
fluoride (PVDF) membrane, and the creation of a single calibration curve to determine the concentration of
either flavone in colon tissue.
These methods allowed for the detection of flavone A
and flavone B in rat colon. Our data indicate that flavone
B was found in higher concentrations in the colon than
flavone A, which may be the result of higher volume of
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distribution value of flavone B [7] compared to that of flavone A.

Methods
Procedure to extract and purify flavones A and B

The compounds were obtained as described before [5].
Briefly, flavone A was purified from dried flowers of Gnaphalium elegans extracted with chloroform using a silica
gel chromatography column. Flavone B was purified
from leaves of Achyrocline bogotensis, using chloroform,
followed by crystallizations in hexane. The physical and
spectroscopic properties of these compounds allowed
their proper identification.
Stock solution and standards

Stock solutions of flavone A at a concentration of 100 µg/
mL, prepared as described previously [7], and 25 µg/mL
celecoxib (Toronto Research Chemicals; Toronto, ON,
CA) were prepared with acetonitrile/water/acetic acid/
triethylamine (60:40:0.2:0.05). Stock solutions of 100 µg/
mL of flavone B, prepared as described previously [7],
and 25 µg/mL diclofenac (MP Biomedicals, LLC; Solon,
OH) were prepared with acetonitrile/water/acetic acid/
trimethylamine (70:30:0.2:0.05). All stock solutions were
stored protected from light at 4 °C. HPLC grade acetonitrile, acetic acid, trimethylamine, and water were purchased from Fisher Scientific (Pittsburgh, PA). Flavone
A or flavone B were mixed with polyethylene glycol 400
(Electron Microscopy Sciences; Hatfield, PA) for intravenous injection.
Sample preparation

Colon tissue was homogenized using a PowerGen 700
from Fisher Scientific (Pittsburgh, PA) in a 1:2 ratio with
water (1 mg/2 mL). Serial concentrations for calibration curves (flavone A: 250–100,000 ng/g and flavone
B: 1000–25,000 ng/g) were prepared. Briefly, 100 μL of
blank homogenate was spiked with 100 μL flavone, 100
µL internal standard (25 µg/mL celecoxib or diclofenac),
and 200 μL of organic solvent (acetonitrile). The samples
were vortex mixed before being centrifuged for 15 min at
3000×g. The supernatant was removed and filtered with
a PDVF filter (0.45 µm) into a clean tube and evaporated
using a Labconco vacuum concentrator (Kansas City,
MO). Mobile phase (200 μL) was used to reconstitute the
residue and 100 μL of sample was injected into the HPLC
column. Analysis was conducted in triplicate.
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HPLC conditions and quantitation

HPLC assays were performed using a Shimadzu liquid
chromatography system (Shimadzu Scientific Instruments Inc., Columbia, Maryland, USA) with an ACE C18
(100 × 4.6 mm) (Aberdeen, Scotland) column. Mobile
phases used for HPLC contained acetonitrile/water
60:40 (flavone A) and 70:30 (flavone B) with 0.2% acetic
acid and 0.05% triethylamine. Detection wavelength was
at 245 nm with a temperature of 30 °C. Flow rate was
0.4 mL/min with run times of 11 and 10 min, respectively. LC solutions program was used to collect and analyze the data.
Animals and drug administration

The methods described here were used to determine the
concentrations of flavone A or flavone B in colon tissue
collected from male Sprague–Dawley rats (Charles River
Laboratories, Raleigh, NC, USA) used in a previous study
[7]. Briefly, flavones were mixed in polyethylene glycol
400 and were administered by intravenous injection to
deliver a 20 mg/kg dose of flavone A (n = 6) or flavone
B (n = 6). Animals were euthanized under anesthesia 6 h
post dosing. Colon tissue was collected and flash frozen
using dry ice and stored at −80 °C until analyzed for the
measurement of concentrations of flavones.

Results
Good separation was achieved (Figs. 1, 2) and the peak
area ratios of flavone against internal standard were
plotted in Excel to make the calibration curves (Fig. 3).
Representative equation for flavone A concentrations 250–100,000 ng/g was y = 2E − 05x + 0.0029
and flavone B concentrations 1000–25,000 ng/g was
y = 7E − 05x + 0.0531 with r2 ≥ 0.99. Three calibration
curves were used to determine the precision (coefficient
of variation—CV) and accuracy of the methods. Data
is presented as mean ± standard deviation (Tables 1,
2). Analysis yielded 1639 ± 601 ng/g of flavone A and
5975 ± 2480 ng/g of flavone B in colon tissue (Fig. 4).
Conclusion
Modifications to the methods developed for extraction and quantification of flavone A and flavone B from
rat colon tissue yield good separation, precision, and
accuracy. The distribution of both flavones to the colon
suggests that they would be good candidates for in vivo
antitumor studies for colon cancer.
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Fig. 1 Elution of flavone A from colon. HPLC chromatographs of a blank colon; b colon spiked with internal standard (celecoxib 25 µg/mL); c colon
spiked with flavone A (100 µg/mL) and internal standard
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Fig. 2 Elution of flavone B from colon. HPLC chromatographs of a blank colon; b colon spiked with internal standard (diclofenac 25 µg/mL); c colon
spiked with flavone B (100 µg/mL) and internal standard
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Fig. 3 Calibration curves were made by graphing the ratio of flavone/internal standard area under the curve extracted from colon tissue versus the
known concentration of flavone. Representative calibration curves for a flavone A and b flavone B are presented

Table 1 Precision and accuracy for 250–100,000 ng/g flavone A extracted from rat colon tissue
Concentration
(ng/g)

Error (%)

Observed
(n = 3)

100,000

13.88 ± 2.14

113,888 ± 2138

1.87 114

11.83 ± 4.15

11,182 ± 415

3.71 111

2848 ± 121

4.27 113

558 ± 129

23.21 111

25,000
10,000
5000
2500
1000
500
250

16.32 ± 1.06

9.93 ± 0.97

13.92 ± 4.87

11.45 ± 8.90

16.65 ± 21.51

21.02 ± 19.30

CV

Accuracy (%)

29,081 ± 265

0.91 116

5496 ± 48

0.88 109

1114 ± 89

285 ± 68

7.98 111
24.03 113

Table 2 Precision and accuracy for 1000–25,000 ng/g flavone B extracted from rat colon tissue
Concentration
(ng/g)
25,000
10,000
5000
2500
1000

Error (%)

Observed
(n = 3)

1.51 ± 0.50

25,204 ± 410

3.69 ± 3.42

4934 ± 271

2.89 ± 0.52

4.22 ± 2.55

25.18 ± 27.00

10,075 ± 345

2480 ± 142

1128 ± 378

CV

Accuracy (%)

1.62 101
3.43 101
5.51

98

5.73

99

33.56 113
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Fig. 4 Distribution of flavones to target tissue. Male Sprague–Dawley
rats received 20 mg/kg of either flavone A or flavone B via intravenous injection. The colon tissues were collected 6 h after dosing and
analyzed for the presence of flavone using a HPLC system
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